Which drugs does patent RE37314 protect, and when does it expire?
Patent RE37314 protects CRESTOR and is included in one NDA. There has been one Paragraph IV challenge on Crestor.
Protection for CRESTOR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-two patent family members in seventeen countries.